Skip to content
lifestyle.clientim.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
GOA Therapeutics Corporation
GOA Therapeutics Presents New Data at ANESTHESIOLOGY® 2026 for GOA26, a First-in-Class Candidate for Acute Alcohol Intoxication and Poisoning
October 23, 2026
GOA Therapeutics Launches $300 Million Stock Offerings to Advance First in Class Drug Candidate for Acute Alcohol Intoxication
October 20, 2026
SEC Qualifies GOA Therapeutics’ Public Offering to Sell Up to $300 Million in Stock; Set for Launch October 15
October 13, 2026
GOA Therapeutics Unveils New Data for GOA26, a First-in-Class Drug Candidate for Acute Alcohol Intoxication and Poisoning
October 8, 2026
GOA Therapeutics Files with SEC for Proposed Public Offering, Contemplates Issuing Up to $300 Million in Stock
September 30, 2026
GOA Therapeutics Emerges from Stealth with $15.5 Million in Funding and Unveils GOA26, a First-in-Class Drug Candidate for Acute Alcohol Intoxication and Poisoning
September 17, 2026